Sociedad Quimica y Minera (SQM)
(Delayed Data from NYSE)
$41.51 USD
+0.09 (0.22%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $41.51 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value C Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.51 USD
+0.09 (0.22%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $41.51 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value C Growth F Momentum D VGM
Zacks News
Best Growth Stocks to Buy for August 17th
by Zacks Equity Research
PERI, SQM, and XOM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 17, 2022.
Flexible Solutions (FSI) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Flexible Solutions (FSI) sees higher sales across its business segments in Q2 on increased customer orders.
Cabot (CBT) Up 11% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
Solid fiscal third quarter results and upbeat outlook have contributed to the run-up in Cabot's (CBT) shares.
Is a Surprise Coming for Sociedad Quimica (SQM) This Earnings Season?
by Zacks Equity Research
Sociedad Quimica (SQM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Sociedad Quimica (SQM) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Sociedad Quimica (SQM) is likely to have gained from higher realized prices and strong demand in the second quarter.
SQM (SQM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, SQM (SQM) closed at $101.78, marking a +0.65% move from the previous day.
Why Nutrien's Strong Results Missed Analyst Estimates
by Sejuti Banerjea
Stronger-than-expected retail pricing and softer-than-expected fertilizer volumes defined the quarter.
Cabot's (CBT) Earnings and Sales Surpass Estimates in Q3
by Zacks Equity Research
Cabot (CBT) gains on higher margins and stronger volumes across the board in the fiscal third quarter.
Century Aluminum (CENX) Q2 Earnings and Sales Lag Estimates
by Zacks Equity Research
Century Aluminum (CENX) sees higher shipments of primary aluminum in the second quarter.
Lithium Likely to Become a De-Facto Precious Metal: 5 Picks
by Nalak Das
We have narrowed our search to five lithium producers. These are: ALB, LTHM, PLL, LAC and SQM.
Kronos Worldwide (KRO) Q2 Earnings Lag Estimates, Sales Beat
by Zacks Equity Research
Kronos Worldwide (KRO) benefits from higher average titanium dioxide selling prices in the second quarter.
ATI's Q2 Earnings and Revenues Beat on Solid Jet Engine Sales
by Zacks Equity Research
ATI gains on continued recovery in the commercial aerospace market and its ongoing transformation actions in the second quarter.
Barrick's (GOLD) Earnings Beat Estimates in Q2, Revenues Lag
by Zacks Equity Research
Barrick (GOLD) benefits from strong performance across the portfolio in Q2 amid challenges from higher costs and lower copper prices.
Scotts Miracle-Gro (SMG) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Scotts Miracle-Gro (SMG) sees lower-than-expected sales in the U.S. Consumer segment and sustained pressure on sales in the Hawthorne unit in Q3.
Ingevity's (NGVT) Earnings and Sales Top Estimates in Q2
by Zacks Equity Research
Ingevity (NGVT) benefits from actions to increase prices to offset inflationary cost pressures in Q2.
Nutrien's (NTR) Earnings and Revenues Lag Estimates in Q2
by Zacks Equity Research
Nutrien (NTR) gains on higher selling prices and strong Retail performance in Q2 amid headwinds from weak volumes in North America and higher natural gas costs.
GrowGeneration (GRWG) Q2 Earnings Miss, Lowers '22 View
by Zacks Equity Research
GrowGeneration (GRWG) reports a drop in Q2 revenues due to the ongoing weakness in the cannabis industry. It lowers revenue guidance to $250 million and $275 million for 2022.
Are Basic Materials Stocks Lagging Nutrien (NTR) This Year?
by Zacks Equity Research
Here is how Nutrien (NTR) and SQM (SQM) have performed compared to their sector so far this year.
This 1 Basic Materials Stock Could Beat Earnings: Why It Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Westlake's (WLK) Earnings & Revenues Surpass Estimates in Q2
by Zacks Equity Research
Westlake (WLK) gains on continued strength in residential construction and remodeling activities in Q2.
Huntsman's (HUN) Earnings and Revenues Top Estimates in Q2
by Zacks Equity Research
Huntsman (HUN) benefits from improved pricing, cost-control actions and its volume strategy in the second quarter.
SQM (SQM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, SQM (SQM) closed at $94.74, marking a -0.22% move from the previous day.
Is Most-Watched Stock Sociedad Quimica y Minera S.A. (SQM) Worth Betting on Now?
by Zacks Equity Research
SQM (SQM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Air Products (APD) Earnings and Sales Beat Estimates in Q3
by Zacks Equity Research
Air Products (APD) gains on increased pricing, higher equity affiliates' income and higher volumes in Q3.
Albemarle (ALB) Beats on Q2 Earnings and Sales, Raises FY22 View
by Zacks Equity Research
Higher pricing on the back of strong demand from diverse end markets drives Albemarle's (ALB) top line in Q2.